Coronavirus: Hydroxychloroquine trialled over better treatments
4 years, 5 months ago

Coronavirus: Hydroxychloroquine trialled over better treatments

Daily Mail  

More than 1,200 studies looking at treatment and prevention of coronavirus are often too small to provide conclusive results and are focusing too much on one potential therapy, a new analysis reveals. Commissioned by STAT News, the report found that one in every six clinical trials studied the anti-malaria drugs hydroxychloroquine or chloroquine despite thin evidence that either are effective at treating patients. About 200 of 1,200 studies - or one in six - looked at anti-malaria drug hydroxychloroquine as a potential treatment for coronavirus Fewer than 25 studies examined dexamethasone or remdesivir, which have been proven to reduce death rates in separate clinical trials. STAT News reports that seven studies in total have looked at dexamethasone with 13,600 patients enrolled, 12,000 of whom were in the RECOVERY trial.

Patients Studies Stat Death Rates Stat News Coronavirus Treatments Drug Hydroxychloroquine  studies  dexamethasone  patients  stat  treatment  drug  hydroxychloroquine  remdesivir  trials  trialled  proven  better  coronavirus  treatments

History of this topic

Panel: Trump staffers pushed unproven COVID treatment at FDA
2 years, 4 months ago

Panel: Trump staffers pushed unproven COVID treatment at FDA

Associated Press  

WASHINGTON — Officials in the Trump White House tried to pressure U.S. health experts into reauthorizing a discredited COVID-19 treatment, according to a congressional investigation that provides new evidence of that administration’s efforts to override Food and Drug Administration decisions early in the pandemic. But Hahn told investigators that he felt pressure due to the “persistence” of Trump aide Peter …

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist
3 years, 2 months ago

New coronavirus anti-viral med is “welcome, but not a miracle cure”: Virologist

NL Times  

Pharmaceutical company Merck announced last week that its antiviral medicine Molnupiravir could prevent 50 percent of coronavirus-related hospital admissions and deaths in high-risk groups if administered in time. According to virologists, this new treatment is a "welcome addition," but not a "miracle cure," they said to NOS. According to him, especially oral administration is "a welcome addition" to the treatment …

WHO Tests 3 Drugs for Treating Coronavirus Infection
3 years, 4 months ago

WHO Tests 3 Drugs for Treating Coronavirus Infection

News 18  

The World Health Organization says it will soon test three drugs used for other diseases to see if they might help patients sickened by the coronavirus. In a statement on Wednesday, the U.N. health agency says the three drugs would be adopted into the next phase of its ongoing global research into identifying potential treatments for COVID-19. The drugs were …

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure
3 years, 6 months ago

Remember Donald Trump-touted hydroxychloroquine? Study in India backs it as Covid-19 cure

India Today  

Hydroxychloroquine, the malaria drug touted as a magical Covid-19 cure by former US President Donald Trump last year, has been found effective in a prophylactic study published in the Journal of The Association of Physicians of India last week. The study said, “hen adjusted for other risk factors, HCQ dose as per government recommendations, 2-3, 4-5, 6 or more weeks …

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria
3 years, 8 months ago

Remdesivir Not Magic Bullet, Does Not Reduce Covid-19 Mortality: AIIMS Chief Randeep Guleria

News 18  

Amid a steep spike in COVID-19 cases leading to increased demand for medicines for treating coronavirus, top health experts in the government on Monday said anti-viral drug remdesivir is "not a magic bullet" and does not reduce mortality. Addressing the media, AIIMS Director Dr Randeep Guleria said remdesivir should only be given to patients hospitalised with moderate illness, who had …

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO
3 years, 8 months ago

Do not use 'miracle cure' ivermectin on COVID-19 patients says WHO

Firstpost  

The World Health Organization said Wednesday that ivermectin — touted by some on social media as a Covid-19 “miracle cure” — should not be used to treat coronavirus patients. The WHO said: “We recommend not to use ivermectin in patients with Covid-19 except in the context of a clinical trial.” Facebook posts and articles endorsing ivermectin have proliferated in Brazil, …

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO
3 years, 9 months ago

Hydroxychloroquine shouldn’t be used as Covid preventive, says WHO

Hindustan Times  

Anti-inflammatory drug hydroxychloroquine should not be used in efforts to prevent infection with Covid-19, according to the World Health Organization. Hydroxychloroquine was touted as a Covid-19 treatment by former President Donald Trump and later deemed ineffective. The WHO’s recommendation is based on evidence from six randomized controlled trials with more than 6,000 participants with or without known exposure to a …

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study
4 years ago

Trial comprising single Covid patient with genetic disorder shows remdesivir's benefits: Study

India Today  

Gilead's antiviral drug remdesivir could be highly effective against coronavirus, a study conducted by British scientists has found. The study, published in the journal Nature Communications involved a single Covid-19 patient with XLA, a rare genetic disorder. Nicholas Matheso, a co-author of the study, told news agency Reuters, "Our patient's unusual condition gave us a rare insight into the effectiveness …

Covid-19: Molnupiravir tablet can be game-changer in stopping coronavirus transmission
4 years ago

Covid-19: Molnupiravir tablet can be game-changer in stopping coronavirus transmission

India Today  

A new drug has become the talk of the town to fight Covid-19. If the experiment carried out in an American university holds true in larger human trials, this could be the magical cure that the world has been waiting for in its fight against Covid-19. The scientists at the Institute of Biomedical Sciences in the American state of Georgia …

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines
4 years, 1 month ago

WHO Suspends Remdesivir from List of COVID-19 Treatment Medicines

The Quint  

In July, Gilead priced Remdesivir at $2,340 for a five-day treatment in the US and some other developed countries, reported Al Jazeera. The WHO panel said, however, that it supported continued enrolment into clinical trials evaluating Remdesivir in patients with COVID-19, which it said should “provide higher certainty of evidence for specific groups of patients”. The WHO’s recommendation is not …

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths
4 years, 1 month ago

WHO advises against use of Remdesivir to treat COVID-19, says drug has no 'important effect' to reduce deaths

Firstpost  

A WHO Guideline Development Group of international experts said there was ’no evidence based on currently available data that the anti-viral drug does improve patient-important outcomes' Paris: The anti-viral drug remdesivir should not be used to treat COVID-19 patients no matter how severe their illness as it has “no important effect” on survival chances, the World Health Organization said Friday. …

WHO advises against use of remdesivir for treating COVID-19
4 years, 1 month ago

WHO advises against use of remdesivir for treating COVID-19

Al Jazeera  

Global health agency says there is no evidence that drug improves survival rates or reduces need for ventilation. A World Health Organization expert panel has advised against the use of the antiviral drug remdesivir for patients admitted to hospital with COVID-19, regardless of how severely ill they are, because there is currently no evidence that it improves survival or the …

Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19
4 years, 2 months ago

Coronavirus | U.S. gives full approval to antiviral remdesivir to treat COVID-19

The Hindu  

The U.S. Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with COVID-19, after conditional authorization was given in May. However, other treatments have received authorization for emergency use, though that approval can be revoked once the public health emergency sparked by the coronavirus pandemic is over. “The FDA …

Remdesivir becomes first Covid-19 treatment to receive FDA approval
4 years, 2 months ago

Remdesivir becomes first Covid-19 treatment to receive FDA approval

CNN  

CNN — The US Food and Drug Administration has approved remdesivir for the treatment of coronavirus infection, the drug’s maker, Gilead Sciences, said Thursday. “Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care.” Earlier this month, a World Health Organization- “The FDA uses data submitted by …

Remdesivir useless in covid fight: WHO
4 years, 2 months ago

Remdesivir useless in covid fight: WHO

Live Mint  

A World Health Organization trial of Gilead Sciences Inc.’s remdesivir, the antiviral drug used to treat US President Donald Trump, showed little or no effect on the survival rates of covid patients, a result that is in variance with the trial reports of the drugmaker. The WHO trial, which also studied the effect of hydroxychloroquine, a combination of HIV drugs …

WHO trial results show remdesivir has little or no effect for covid-19 patients
4 years, 2 months ago

WHO trial results show remdesivir has little or no effect for covid-19 patients

Live Mint  

Interim results from the World Health Organization’s solidarity trial showed that Gilead Sciences Inc’s remdesivir showed little or no effect for covid-19 patients, a result which was significantly different from the positive results shown by Gilead’s own trial. “These remdesivir, hydroxychloroquine, lopinavir and interferon regimens appeared to have little or no effect on hospitalized covid-19 patients, as indicated by overall …

Coronavirus | Repurposed drugs did not cut down mortality, says WHO
4 years, 2 months ago

Coronavirus | Repurposed drugs did not cut down mortality, says WHO

The Hindu  

Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, have indicated that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalised patients as per information released by the World Health Organisation. Speaking exclusively to The Hindu, about the outcome Prof. K …

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir
4 years, 2 months ago

WHO: Study finds four drugs that have little to no effect on coronavirus, including remdesivir

India Today  

The World Health Organisation announced Friday the long-awaited results of its six-month “Solidarity Therapeutics Trial” that endeavored to see if existing drugs might have an effect on the coronavirus. What the study found The study, which was not peer-reviewed, found that four treatments tested - remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon - had “ little or no effect" on whether or …

WHO trial finds remdesivir has little effect on COVID-19
4 years, 2 months ago

WHO trial finds remdesivir has little effect on COVID-19

Al Jazeera  

Early results from large, randomised trial suggest antiviral does little to reduce mortality rates or time in hospital. A World Health Organization trial using four drugs including the antiviral remdesivir in the hospital treatment of COVID-19 has found the repurposed medicines have little to no effect on the length of time patients spend in hospital or their survival. “These Remdesivir, …

Race for coronavirus treatment hits reality as complications mount
4 years, 2 months ago

Race for coronavirus treatment hits reality as complications mount

Live Mint  

The sprint to find medical breakthroughs to contain Covid-19 stumbled this week, as a pair of pharmaceutical giants working to develop treatments and vaccines suffered setbacks in the clinic. J&J Chief Financial Officer Joseph Wolk said in an interview the company doesn’t know whether the person who was sickened had received the vaccine or a placebo. We aren’t making decisions …

If I catch covid-19, can I get the medications Donald Trump received?
4 years, 2 months ago

If I catch covid-19, can I get the medications Donald Trump received?

Live Mint  

Here’s what we know about treatments Trump received—and how a person on some of those medicines might be faring at this point in their care It has been more than a week since President Trump was diagnosed with Covid-19, the illness caused by the novel coronavirus, and his physician said Thursday that he has completed his course of therapy. It …

Trump Was Treated With Steroids: How These Drugs Are Used For COVID-19 Patients
4 years, 2 months ago

Trump Was Treated With Steroids: How These Drugs Are Used For COVID-19 Patients

NPR  

Trump Was Treated With Steroids: How These Drugs Are Used For COVID-19 Patients Enlarge this image toggle caption Nati Harnik/AP Nati Harnik/AP Editor's note: Since we published this story, Trump's physician said that the president has completed his treatment for COVID-19. The steroid, dexamethasone, is now part of the "standard of care" for COVID-19, said Dr. Celine Gounder, assistant professor …

WHAT ARE THE DRUGS TRUMP IS BEING TREATED WITH?
4 years, 2 months ago

WHAT ARE THE DRUGS TRUMP IS BEING TREATED WITH?

Daily Mail  

President Trump has been given at least three potent drugs since announcing he tested positive for COVID-19 on Thursday night: Regeneron's cocktail of lab-made antibodies, the antiviral remdesivir, and the steroid dexamethasone. The drugs he was treated with and their potential side effects are: REGENERON'S EXPERIMENTAL ANTIBODY COCKTAIL DRUG WHEN HE GOT IT: Trump received a single 8 gram dose …

Netherlands has shortage of Covid medicine Remdesivir
4 years, 2 months ago

Netherlands has shortage of Covid medicine Remdesivir

NL Times  

Dutch hospitals are currently unable to order virus inhibitor Remdesivir, used to treat the coronavirus. The last available doses were sent out on Sunday, public health institute RIVM and the Ministry of Public Health, Welfare and Sports said to Financieele Dagblad. Last month, Minister Hugo de Jonge of Public Health said that the Netherlands' healthcare system was well prepared for …

Dexamethasone: What is the new life-saving coronavirus drug?
4 years, 2 months ago

Dexamethasone: What is the new life-saving coronavirus drug?

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Medical Experts Raise Questions About Severity Of Trump's COVID-19 Infection
4 years, 2 months ago

Medical Experts Raise Questions About Severity Of Trump's COVID-19 Infection

Huff Post  

LOADING ERROR LOADING - Doctors not involved in treating President Donald Trump for COVID-19 said the fact that he has been started on dexamethasone - a generic steroid widely used in other diseases to reduce inflammation - is evidence his case is severe. “What I heard in the news conference description suggested the President has more severe illness than the …

How President Trump Is Treating COVID-19
4 years, 2 months ago

How President Trump Is Treating COVID-19

NPR  

How President Trump Is Treating COVID-19 There are no proven treatments for patients with COVID-19, and the treatments that do exist tend to be used on patients with advanced illness. But, of course, when you're first testing a drug, you want to start it off with the sickest patients, so that's where it's been shown to work. PALCA: Well, according …

Trump Is Taking Remdesivir. Here's How It Works To Control The Coronavirus
4 years, 2 months ago

Trump Is Taking Remdesivir. Here's How It Works To Control The Coronavirus

NPR  

Trump Is Taking Remdesivir. Here's How It Works To Control The Coronavirus Enlarge this image toggle caption Susan Walsh/AP Susan Walsh/AP President Trump, hospitalized at Walter Reed National Military Medical Center in Maryland, is being treated with remdesivir, an antiviral drug made by Gilead Sciences. Remdesivir isn't a perfect copy-blocking machine, but it works well enough to slow the release …

Steroids can be lifesaving for a few seriously ill COVID-19 patients, new studies suggests
4 years, 3 months ago

Steroids can be lifesaving for a few seriously ill COVID-19 patients, new studies suggests

Firstpost  

WHO warned against indiscriminate use of steroids, emphasizing that patients who are not severely ill are unlikely to benefit and may suffer side effects. International clinical trials published Wednesday confirm the hope that cheap, widely available steroid drugs can help seriously ill patients survive COVID-19, the illness caused by the coronavirus. Based on the new evidence, the World Health Organization …

Steroids Confirmed To Help Severely Ill Coronavirus Patients
4 years, 3 months ago

Steroids Confirmed To Help Severely Ill Coronavirus Patients

News 18  

New studies confirm that multiple types of steroids improve survival for severely ill COVID-19 patients, cementing the cheap drugs as a standard of care. An analysis of pooled results from seven studies, led by the World Health Organization and published Wednesday by the Journal of the American Medical Association, found that steroids reduced the risk of death in the first …

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients
4 years, 3 months ago

FDA approves expanded emergency use of remdesivir in moderate COVID-19 patients

The Hindu  

Gilead Inc said on Friday the U.S. Food and Drug Administration expanded the emergency use authorization of its experimental antiviral COVID-19 treatment, remdesivir, to allow its use in all hospitalized COVID-19 patients. The drug was authorized in May for use in patients with a severe form of the illness, after trial data showed the antiviral drug helped shorten hospital recovery …

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment
4 years, 4 months ago

Amsterdam study shows hydroxychloroquine ineffective in Covid-19 treatment

NL Times  

Hydroxychloroquine was not effective in treating Covid-19 in Dutch hospitals during the coronavirus crisis, according to a study by Amsterdam scientists led by internist-infectiologist Edgar Peters of Amsterdam UMC. The Amsterdam researchers compared seven hospitals where Hydroxychloroquine was included in the treatment guideline in the early months of the crisis, to two hospitals where the drug was not prescribed. In …

Oleandrin treatment for coronavirus is ‘nonsense’ right now, experts say
4 years, 4 months ago

Oleandrin treatment for coronavirus is ‘nonsense’ right now, experts say

CNN  

CNN — Is the White House about to promote a new, unproven and sketchy coronavirus treatment? “This is really just nonsense and a distraction,” Dr. Jonathan Reiner, CNN medical analyst and a professor of medicine at George Washington University, told CNN’s Anderson Cooper. “Even after animal testing it could still fail in clinical trials.” Last week, Lindell was added to …

Where are we in finding a treatment for COVID-19?
4 years, 4 months ago

Where are we in finding a treatment for COVID-19?

Al Jazeera  

Some drugs and treatments have shown promise in clinical trials, while others are drawing controversy. More information on the efficacy of remdesivir in patients with COVID-19 is expected from large clinical trials such as the WHO-coordinated Solidarity Trial and the Recovery Trial in the United Kingdom. “It’s really important that these drugs be evaluated in robust clinical trials before being …

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times
4 years, 4 months ago

Hydroxychloroquine is a poor coronavirus treatment but a perfect parable for our times

ABC  

The group had all the trappings of medical authority. Since March 1, public posts containing the word "hydroxychloroquine" have received at least 55 million "interactions" on Facebook — a measure that includes reactions, shares or comments. And in the months since, President Trump and members of his administration have repeatedly returned to the hydroxychloroquine narrative despite the protests of White …

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection
4 years, 4 months ago

Trump Defends Use of Hydroxychloroquine, Says It Works in Early Stages of Covid-19 Infection

News 18  

US President Donald Trump has again defended the use of hydroxychloroquine to ward off coronavirus, saying many frontline medical workers agree with him that the malaria drug works in the early stages of COVID-19 infection, despite mounting evidence that it is ineffective in treating the disease. I think frontline medical people believe that too — some, many," Trump told reporters …

Hydroxychloroquine: Trump defends disproved Covid-19 treatment
4 years, 4 months ago

Hydroxychloroquine: Trump defends disproved Covid-19 treatment

Live Mint  

President Donald Trump issued a stout defense Tuesday of a disproved use of a malaria drug as a treatment for the coronavirus, hours after social media companies moved to take down videos promoting its use as potentially harmful misinformation. Trump, his son Donald Trump Jr., and others shared video of the event on Facebook and Twitter, prompting both companies to …

Warnings against anti-malaria drug hydroxychloroquine to treat Covid-19 patients were politically motivated: Donald Trum
4 years, 4 months ago

Warnings against anti-malaria drug hydroxychloroquine to treat Covid-19 patients were politically motivated: Donald Trum

Live Mint  

US President Donald Trump said the medical community’s widespread warnings against using the anti-malaria drug hydroxychloroquine to treat Covid-19 patients were politically motivated to damage him. Trump had shared a video of people dressed in white lab coats who called themselves “America’s Frontline Doctors” staging a press conference about the virus. “He’s got a pretty good approval rating, so just …

Video falsely touts hydroxychloroquine as COVID-19 cure
4 years, 4 months ago

Video falsely touts hydroxychloroquine as COVID-19 cure

Associated Press  

CLAIM: A video makes numerous claims about preventing the coronavirus, stating that hydroxychloroquine can prevent and cure COVID-19, and wearing masks and keeping people locked down have no value. “There is no evidence done in a rigorous study that shows hydroxychloroquine in combination with azithromycin or zinc or whatever combination you use that has any benefit in the treatment of …

Trump again pushes unproven hydroxychloroquine as Covid-19 treatment
4 years, 4 months ago

Trump again pushes unproven hydroxychloroquine as Covid-19 treatment

Live Mint  

WASHINGTON: A week after appearing to project a more serious tone about the coronavirus, President Donald Trump is back to pushing unproven claims that an anti-malaria drug is an effective treatment and challenging the credibility of the nation's leading infectious disease expert. The president also shared a post from the Twitter account for a podcast hosted by Steve Bannon, a …

Scientists identify 21 existing drugs that block coronavirus in lab studies
4 years, 4 months ago

Scientists identify 21 existing drugs that block coronavirus in lab studies

Live Mint  

Scientists, including those of Indian-origin, have identified 21 existing drugs that stop the replication of the novel coronavirus which causes COVID-19 in lab studies, an advance that may lead to the development of new therapeutic combinations against the disease. Of the 21 drugs that were effective at blocking viral replication, the scientists found that 13 have previously entered clinical trials …

July 16 coronavirus news
4 years, 5 months ago

July 16 coronavirus news

CNN  

A pharmacy tech pours out hydroxychloroquine pills in May. George Frey/AFP/Getty Images The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild symptoms from Covid-19 who were treated early in their infection, according to a study to be published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either …

Hydroxychloroquine doesn’t work in non-hospitalized patients
4 years, 5 months ago

Hydroxychloroquine doesn’t work in non-hospitalized patients

CNN  

CNN — The antimalarial drug hydroxychloroquine did not benefit non-hospitalized patients with mild Covid-19 symptoms who were treated early in their infection, according to a study published Thursday in the medical journal Annals of Internal Medicine. “Taken together, there is no convincing evidence that hydroxychloroquine can either prevent COVID-19 after exposure or reduce illness severity after developing early symptoms,” study …

One in three South Korean Covid-19 patients improve with remdesivir
4 years, 5 months ago

One in three South Korean Covid-19 patients improve with remdesivir

India Today  

One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condition after being given Gilead Sciences Inc's antiviral remdesivir, health authorities said. Remdesivir has been at the forefront of the global battle against COVID-19 after the intravenously administered medicine helped shorten hospital recovery times in a U.S. clinical trial. In its latest update on the …

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed
4 years, 5 months ago

Gilead says remdesivir reduced risk of death in coronavirus patients, more studies needed

India Today  

Gilead Sciences Inc said on Friday additional data from a late-stage study showed its antiviral remdesivir reduced the risk of death and significantly improved the conditions of severely ill COVID-19 patients. Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with similar characteristics and disease severity as …

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds
4 years, 5 months ago

US prescriptions for hydroxychloroquine skyrocketed from February to March, study finds

CNN  

CNN — Prescriptions for the anti-malarial drugs chloroquine and hydroxychloroquine skyrocketed in the US from February to March, a time when the drugs, though unproven, were touted as treatments for the coronavirus. Researchers found the estimated number of hydroxychloroquine prescriptions increased 86.2% from February to March, from 367,346 to 683,999, and dispensed chloroquine prescriptions increased 158.6%, rising from 2,346 to …

WHO ending hydroxychloroquine trial for COVID
4 years, 5 months ago

WHO ending hydroxychloroquine trial for COVID

LA Times  

The World Health Organization says it is ending a trial into whether the anti-malaria drug hydroxychloroquine helps patients hospitalized with COVID-19. The WHO said Saturday it has “accepted the recommendation” from the committee overseeing the trial to discontinue testing of hydroxychloroquine and lopinavir/ritonavir, a drug combination used to treat HIV/AIDS. The United Nations agency says a review of the interim …

Study finds hydroxychloroquine helped coronavirus patients survive better
4 years, 5 months ago

Study finds hydroxychloroquine helped coronavirus patients survive better

CNN  

CNN — A surprising new study found the controversial antimalarial drug hydroxychloroquine helped patients better survive in the hospital. A team at Henry Ford Health System in southeast Michigan said Thursday their study of 2,541 hospitalized patients found that those given hydroxychloroquine were much less likely to die. The US Food and Drug Administration withdrew its emergency use authorization for …

Centre includes includes dexamethasone drug in COVID-19 treatment protocol for moderate to severe cases
4 years, 5 months ago

Centre includes includes dexamethasone drug in COVID-19 treatment protocol for moderate to severe cases

Firstpost  

The updated protocol includes the advice to use dexamethasone as an alternative choice to methylprednisolone for managing moderate to severe cases of COVID-19. New Delhi: An inexpensive, widely used steroid dexamethasone was included in the treatment protocols for COVID-19 patients in moderate to severe stages of illness among other therapeutic measures by the Union health ministry on Saturday. According to …

Discover Related